Found: 2

Select item for more details and to access through your institution.

  • Pembrolizumab as first-line treatment for metastatic uveal melanoma.

    Published in:
    Cancer Immunology, Immunotherapy, 2019, v. 68, n. 7, p. 1179, doi. 10.1007/s00262-019-02352-6
    By:
    • Rossi, Ernesto;
    • Pagliara, Monica Maria;
    • Orteschi, Daniela;
    • Dosa, Tommaso;
    • Sammarco, Maria Grazia;
    • Caputo, Carmela Grazia;
    • Petrone, Gianluigi;
    • Rindi, Guido;
    • Zollino, Marcella;
    • Blasi, Maria Antonietta;
    • Cassano, Alessandra;
    • Bria, Emilio;
    • Tortora, Giampaolo;
    • Schinzari, Giovanni
    Publication type:
    Article

  • Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma.

    Published in:
    Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00232
    By:
    • Rossi, Ernesto;
    • Maiorano, Brigida Anna;
    • Pagliara, Monica Maria;
    • Sammarco, Maria Grazia;
    • Dosa, Tommaso;
    • Martini, Maurizio;
    • Rindi, Guido;
    • Bria, Emilio;
    • Blasi, Maria Antonietta;
    • Tortora, Giampaolo;
    • Schinzari, Giovanni
    Publication type:
    Article